کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3328146 | 1212300 | 2013 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Leczenie podtrzymujÄ
ce w szpiczaku plazmocytowym
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
ایمونولوژی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Leczenie podtrzymujÄ
ce w szpiczaku plazmocytowym Leczenie podtrzymujÄ
ce w szpiczaku plazmocytowym](/preview/png/3328146.png)
چکیده انگلیسی
Multiple myeloma (MM) remains the incurable disease despite considerable progress in chemotherapy. Optimal way of maintenance treatment is still searching, which it would be maximally effective near acceptable toxicity. The hypothesis about possible successful maintenance therapy, which may improve survival of MM patients became more actual in the face of the incorporate to the studies with maintenance of a new drugs as: thalidomide, lenalidomide and bortesomib. The expectations on the essential progress to establish the optimal bortesomib-based regimen of the maintenance treatment in MM cause the results of the studies with its subcutaneous administration, which proved comparable efficacy with advantage in toxicity profile, especially neurological in comparison to classic intravenous way. The standard of the maintenance treatment for multiple myeloma patients is not established. Individual therapeutic approach after induction-consolidation phase using the most effective drugs is recommended in every case.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Acta Haematologica Polonica - Volume 44, Issue 2, AprilâJune 2013, Pages 116-123
Journal: Acta Haematologica Polonica - Volume 44, Issue 2, AprilâJune 2013, Pages 116-123
نویسندگان
Sebastian Grosicki,